These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Contribution of APC and MUTYH mutations to familial adenomatous polyposis susceptibility in Hungary. Papp J, Kovacs ME, Matrai Z, Orosz E, Kásler M, Børresen-Dale AL, Olah E. Fam Cancer; 2016 Jan; 15(1):85-97. PubMed ID: 26446593 [Abstract] [Full Text] [Related]
4. Low frequency of AXIN2 mutations and high frequency of MUTYH mutations in patients with multiple polyposis. Lejeune S, Guillemot F, Triboulet JP, Cattan S, Mouton C, PAFNORD Group, Porchet N, Manouvrier S, Buisine MP. Hum Mutat; 2006 Oct; 27(10):1064. PubMed ID: 16941501 [Abstract] [Full Text] [Related]
5. Clinical characterization and mutation spectrum in patients with familial adenomatous polyposis in China. Li N, Kang Q, Yang L, Zhao XJ, Xue LJ, Wang X, Li AQ, Li CG, Sheng JQ. J Gastroenterol Hepatol; 2019 Sep; 34(9):1497-1503. PubMed ID: 31062380 [Abstract] [Full Text] [Related]
6. Correlation between mutations and mRNA expression of APC and MUTYH genes: new insight into hereditary colorectal polyposis predisposition. Aceto GM, Fantini F, De Iure S, Di Nicola M, Palka G, Valanzano R, Di Gregorio P, Stigliano V, Genuardi M, Battista P, Cama A, Curia MC. J Exp Clin Cancer Res; 2015 Oct 28; 34():131. PubMed ID: 26511139 [Abstract] [Full Text] [Related]
7. The first mutations in the MYH gene reported in Moroccan colon cancer patients. Laarabi FZ, Cherkaoui Jaouad I, Baert-Desurmont S, Ouldim K, Ibrahimi A, Kanouni N, Frebourg T, Sefiani A. Gene; 2012 Mar 15; 496(1):55-8. PubMed ID: 22266422 [Abstract] [Full Text] [Related]
12. Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis. Nielsen M, Hes FJ, Nagengast FM, Weiss MM, Mathus-Vliegen EM, Morreau H, Breuning MH, Wijnen JT, Tops CM, Vasen HF. Clin Genet; 2007 May 01; 71(5):427-33. PubMed ID: 17489848 [Abstract] [Full Text] [Related]
13. Mutation analysis of MUTYH in Japanese colorectal adenomatous polyposis patients. Taki K, Sato Y, Nomura S, Ashihara Y, Kita M, Tajima I, Sugano K, Arai M. Fam Cancer; 2016 Apr 01; 15(2):261-5. PubMed ID: 26684191 [Abstract] [Full Text] [Related]
14. Implication of adenomatous polyposis coli and MUTYH mutations in familial colorectal polyposis. De Rosa M, Galatola M, Borriello S, Duraturo F, Masone S, Izzo P. Dis Colon Rectum; 2009 Feb 01; 52(2):268-74. PubMed ID: 19279422 [Abstract] [Full Text] [Related]
18. [From gene to disease; MutYH-associated polyposis coli (MAP)]. Nielsen M, Weiss MM, Vasen HF, Hes FJ. Ned Tijdschr Geneeskd; 2005 Dec 31; 149(53):2970-2. PubMed ID: 16425850 [Abstract] [Full Text] [Related]
19. APC or MUTYH mutations account for the majority of clinically well-characterized families with FAP and AFAP phenotype and patients with more than 30 adenomas. Filipe B, Baltazar C, Albuquerque C, Fragoso S, Lage P, Vitoriano I, Mão de Ferro S, Claro I, Rodrigues P, Fidalgo P, Chaves P, Cravo M, Nobre Leitão C. Clin Genet; 2009 Sep 31; 76(3):242-55. PubMed ID: 19793053 [Abstract] [Full Text] [Related]
20. Somatic c.34G>T KRAS mutation: a new prescreening test for MUTYH-associated polyposis? Aimé A, Coulet F, Lefevre JH, Colas C, Cervera P, Flejou JF, Lascols O, Soubrier F, Parc Y. Cancer Genet; 2015 Sep 31; 208(7-8):390-5. PubMed ID: 26056087 [Abstract] [Full Text] [Related] Page: [Next] [New Search]